mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health

Sponsor
Hospital Clinic of Barcelona (Other)
Overall Status
Recruiting
CT.gov ID
NCT05669040
Collaborator
Amgen (Industry), University of Barcelona (Other)
278
1
3
4.3
64.6

Study Details

Study Description

Brief Summary

The present study aims to evaluate the effectiveness of a pharmacological nursing educational intervention (EFE) with "Myplan Aplication" about the patient's experience, adherence to pharmacological treatment, and positive mental health of patients with femur fracture.

Condition or Disease Intervention/Treatment Phase
  • Other: Pharmacological education
  • Other: Training in the use of MyPlan Aplication
  • Other: Patient Experience
N/A

Detailed Description

Once the informed consent has been obtained, the investigators will explain to the patient the pharmacological treatment with the support of an aplication (what it is for, how the medication should be taken, possible adverse effects), also the investigators will share time with the patient during the 4 face-to-face training sessions. The investigators will accompany during their hospital stay, offering to pacients telematic support upon discharge with the treatment and until the end of the study. This is a quasi-experimental non-randomized study with 3 phases of data collection. Possible adverse reactions, if any, will be recorded.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
278 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Primary Purpose:
Supportive Care
Official Title:
mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health of Patients Diagnosed With Femur Fracture: Protocol for a Quasi-experimental Study
Actual Study Start Date :
Nov 21, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Patient experience

Other: Pharmacological education
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.

Other: Training in the use of MyPlan Aplication
Review of the use of the aplication

Other: Patient Experience
How do you feel? Sad feelings and frustration. Achievements day by day, think positive. Importance of interpersonal relationships. Explain activities to relax the mind

Active Comparator: Adherence to drug treatment

Other: Pharmacological education
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.

Other: Training in the use of MyPlan Aplication
Review of the use of the aplication

Active Comparator: Positive mental health

Other: Patient Experience
How do you feel? Sad feelings and frustration. Achievements day by day, think positive. Importance of interpersonal relationships. Explain activities to relax the mind

Outcome Measures

Primary Outcome Measures

  1. Patient experience questionnaire-15. Changes in outcomes are assessed at three time points. [at 1rst day (before intervention), at 7th day (at discharge after intervention), and 25th day (after discharge)]

    This questionnaire allows us to explore the perception of patients about the information process and participation in decision-making during hospital admission. The responses range is from always or almost always/quite frequently/sometimes/never or almost never.This questionnaire allows us to explore the perception of patients about the information process and participation in decision-making during hospital admission. The responses range from always or almost always/quite frequently/sometimes/never or almost never.

  2. Morinski-Green Questionnaire. Changes in outcomes are assessed at three time points. [at 1rst day, at 7th day and 25th day.]

    This questionnaire allows assessing adherence to the prescribed treatment. It consists of a series of 4 dichotomous yes/no questions that reflects the degree of behavior of the patient's compliance, information on the causes of non-compliance.

  3. Positive Mental Health Questionnaire. Changes in outcomes are assessed at three time points. [at 1rst day, at 7th day and 25th day.]

    This scale evaluates mental health from a positive perspective. It consists of 39 items distributed in six factors: personal satisfaction, pro-social attitude, self-control, autonomy, problem solving and self-acting, and interpersonal relationship skills. Its measurement is carried out by means of a Likert-type response that goes from always or almost always, quite frequently, sometimes, never or almost never. Validated in the general population in favorable psychometric values: global reliability of 0.88 and an applied variance of 45%.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosis of femur fracture

  • knowledge of the Spanish language

  • 24-hour admission to the traumatology unit

  • level of consciousness on the Glasgow scale of 15

  • have access to a mobile device

  • ability to participate in the pilot study

  • be able to provide written informed consent or obtain consent from a legal representative.

Exclusion Criteria:
  • presence of psychological pathologies or cognitive impairment

  • isolation in hospital admission

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Clinic de Barcelona Barcelona Spain 08036

Sponsors and Collaborators

  • Hospital Clinic of Barcelona
  • Amgen
  • University of Barcelona

Investigators

  • Study Director: Carmen Moreno Arroyo, UB

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gemma Marcos, Principal Investigator, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT05669040
Other Study ID Numbers:
  • Intervention EFE
First Posted:
Dec 30, 2022
Last Update Posted:
Dec 30, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gemma Marcos, Principal Investigator, Hospital Clinic of Barcelona
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 30, 2022